Perfluorooctane Sulfonate Exposure and Peripheral Artery Disease: Mendelian Randomization and Integrative Multi‐Omics Systems Toxicology With Machine Learning
Chemical Biology & Drug Design · 2026-07 · 108 (1)
DOI: 10.1111/cbdd.70352 ↗At a glance
Journal article in Chemical Biology & Drug Design, published online on 2026-07-03. Written by Xi Lan and 9 co-authors. Institution: Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. Major MEDLINE topics: Alkanesulfonic Acids, Machine Learning, Fluorocarbons, Peripheral Arterial Disease. 61 references.
Abstract (original language)
Epidemiological and experimental studies have linked legacy and emerging PFAS to adverse cardiovascular outcomes, yet most evidence remains observational and is susceptible to confounding, measurement error, and reverse causation. This study used European‐ancestry GWAS data and two‐sample Mendelian randomization to assess potential causal associations between PFOA or PFOS exposure and five cardiovascular diseases. For significant MR findings, network toxicology was integrated with transcriptomic data to identify candidate targets and pathways, followed by machine learning‐based prioritization. Immune cell infiltration, single‐cell transcriptomic analysis, molecular docking, and molecular dynamics simulation were further applied to explore immune mechanisms and pollutant–protein interactions. Genetically predicted PFOS exposure was associated with an increased risk of peripheral artery disease. Enrichment analysis implicated PPAR and PI3K–Akt signaling pathways, while machine learning based on 129 overlapping genes identified HMOX1, KDR, MMP9, and PPARG as key targets. Immune infiltration and single‐cell analyses indicated remodeling of the PAD immune microenvironment, with HMOX1 mainly enriched in macrophages. Virtual knockout highlighted APC‐related MHC II antigen presentation, and docking and dynamics simulations supported stable PFOS–HMOX1 binding. These findings suggest a potential PFOS–PAD association and provide candidate biomarkers for further validation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Chengdu Shuangliu Hospital of Traditional Chinese Medicine, Chengdu, China.
- School of Nursing, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- The Second Hospital, Jilin University Department of Hepatopancreatobiliary Medicine, Jilin, China.
- Department of Cardiology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China.
- Suzhou Key Laboratory of Cardiovascular Disease, Suzhou, China.
ORCID profiles: Xi Lan, Jinhao Zeng
Cite
APA
Lan, X., Wu, Q., Zhou, J., Jiang, J., Yang, G., Yang, H., Chen, Y., Zeng, J., Han, C., & Yang, J. (2026). Perfluorooctane Sulfonate Exposure and Peripheral Artery Disease: Mendelian Randomization and Integrative Multi‐Omics Systems Toxicology With Machine Learning. Chemical Biology & Drug Design, 108(1). https://doi.org/10.1111/cbdd.70352
Vancouver
Lan X, Wu Q, Zhou J, Jiang J, Yang G, Yang H, et al. Perfluorooctane Sulfonate Exposure and Peripheral Artery Disease: Mendelian Randomization and Integrative Multi‐Omics Systems Toxicology With Machine Learning. Chemical Biology & Drug Design. 2026;108(1). doi:10.1111/cbdd.70352
BibTeX
@article{Lan2026,
author = {Lan, Xi and Wu, Qiang and Zhou, Jun and Jiang, Jiajie and Yang, Guixin and Yang, Heng and Chen, Yanyu and Zeng, Jinhao and Han, Caili and Yang, Jiaming},
title = {Perfluorooctane Sulfonate Exposure and Peripheral Artery Disease: Mendelian Randomization and Integrative Multi‐Omics Systems Toxicology With Machine Learning},
journal = {Chemical Biology & Drug Design},
year = {2026},
volume = {108},
number = {1},
doi = {10.1111/cbdd.70352}
}
EUVIMED